Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View
  Buy Now:   Buy PDF- 62pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5807670: Detection of hepatitis GB virus genotypes
[ Derwent Title ]

Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
62 pages

 
Inventor: Muerhoff, Anthony Scott; Kenosha, WI
Simons, John N.; Grayslake, IL
Leary, Thomas P.; Kenosha, WI
Birkenmeyer, Larry; Chicago, IL
Erker, James C.; Hainesville, IL
Chalmers, Michelle; Lake Villa, IL
Dawson, George J.; Libertyville, IL
Desai, Suresh M.; Libertyville, IL
Mushahwar, Isa K.; Grayslake, IL

Assignee: Abbott Laboratories, Abbott Park, IL
other patents from ABBOTT LABORATORIES (735) (approx. 2,979)
 News, Profiles, Stocks and More about this company

Published / Filed: 1998-09-15 / 1995-12-21

Application Number: US1995000580038
IPC Code: Advanced: C07K 14/18; C12N 15/09; C12N 15/11; C12N 15/86; C12Q 1/70; G01N 33/566; G01N 33/576;
Core: C07K 14/005; more...
IPC-7: C12Q 1/70;

ECLA Code: C07K14/18F6; C12N15/11B1; C12N15/86; C12Q1/70B6A; M07K205/00; M07K207/00; M07K213/02; M07K319/00; M12N301/450; M12N301/482; M12N301/500+918; M12N840/20A; M12Q220/114F23; M12Q220/114X14; M12Q220/214;

U.S. Class: Current: 435/005; 536/023.72; 536/024.32;
Original: 435/005; 536/023.72; 536/024.32;

Field of Search: 435/005,320.1 536/23.72,24.32,24.33

Priority Number:
1995-12-21  US1995000580038

Abstract:     HGBV-C oligonucleotides from the 5' end of HGBV-C useful for the detection and genotyping of HGBV-C isolates. Also provided are assays which utilize these oligonucleotides.

Attorney, Agent or Firm: Porembski, Priscilla E. ; Casuto, Dianne ;

Primary / Asst. Examiners: Houtteman, Scott W.;

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

Designated Country: AT BE CH DE ES FR GB IT LI NL  CA EP JP 

Family: Show 12 known family members
First Claim:
Show all 23 claims		 We claim:     1. A composition of matter comprising an oligonucleotide consisting of SEQ ID NO: 51 and complements thereof.

Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 5 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (5)   |   Backward references (6)   |   Citation Link

Buy
PDF		 Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 17pp US4743535  1988-05 Carrico  Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
Buy PDF- 13pp US4876187  1989-10 Duck et al.  Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
Buy PDF- 28pp US5275947  1994-01 Arima et al.  The Research Foundation for Microbial Disease of Osaka University Non-A, non-B hepatitis virus antigen peptide
Buy PDF- 16pp US5399346  1995-03 Anderson et al.  The United States of America as represented by the Department of Health and Human Services Gene therapy
Buy PDF- 30pp US5527669  1996-06 Resnick et al.  Hoffmann-La Roche Inc. Methods, primers and probes for detection of hepatitis C and novel variants
Buy PDF- 18pp US5576302  1996-11 Cook et al.  ISIS Pharmaceuticals, Inc. Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity
       
Foreign References:
Buy
PDF		 Publication Date IPC Code Assignee   Title
Buy PDF- 138pp EP0318216 1989-05  A61K 39/29 CHIRON CORP Nanbv diagnostics and vaccines 
Buy PDF- 56pp WO9000597 1990-01  C12N 7/00 GENELABS INC POST-TRANSFUSION, NON-A, NON-B HEPATITIS VIRUS AND ANTIGENS 
Buy PDF- 39pp WO9408002 1994-04  C12N 15/09 CHIRON CORP METHODS AND COMPOSITIONS FOR CONTROLLING TRANSLATION OF HCV PROTEINS 
Buy PDF- 67pp WO9418217 1994-08  A61K 39/00 ABBOTT LABORATORIES NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS REAGENTS AND METHODS FOR THEIR USE 
Buy PDF- 300pp WO9532292 1995-11  C07K 14/005 FRY, Kirk, E. DETECTION OF VIRAL ANTIGENS CODED BY REVERSE-READING FRAMES 
Buy PDF- 166pp WO9532290 1995-11  A61K 38/00 GENELABS TECHNOLOGIES, INC. NON-A/NON-B/NON-C/NON-D/NON-E HEPATITIS AGENTS AND MOLECULAR CLONING THEREOF 
Buy PDF WO9532291 1995-11  C12N 15/40 GENELABS TECH INC HEPATITIS G VIRUS AND MOLECULAR CLONING THEREOF 
Buy PDF- 21pp WO9506266 1996-05  C08F 218/00 AKZO NOBEL N.V. OPHTHALMIC LENSES 


Other Abstract Info: CHEMABS 126(18)235854R CHEMABS 126(20)260130J DERABS C1997-165306 DERABS C1997-179430

Other References:
  • S. Chan et al., Journal of General Virology, 73:1131-1141 (1992). (11 pages) Cited by 48 patents [ISI abstract]
  • A. Muerhoff et al., Journal of Virology 69 (9), 5621-5630 (1995). (10 pages) Cited by 17 patents [ISI abstract]
  • Gura, Sciencevol. 270 pp. 575-577 (1995). (3 pages) Cited by 302 patents [ISI abstract]
  • Brown, Washington Postpp. 1 & A22 (Dec. 8, 1995).
  • Choo et al., Proc. Natl. Acad. Sci. USA, vol. 88, pp. 2451-2455 (1991). (5 pages) Cited by 117 patents [ISI abstract]
  • Okamoto et al., "Polyprotein precursor--hepatitis C virus", EMBL Sequence Accession No. S40770, Submitted Mar. 1992.
  • Okamoto et al., Virology, vol. 188, pp. 331-341 (1992). (11 pages) Cited by 63 patents [ISI abstract]
  • A. Takamizawa et al., Journal of Virology, vol. 65, No. 3, pp. 1105-1113 (1991). (9 pages) Cited by 89 patents [ISI abstract]
  • S. K. Kuwada et al., The American Journal of Gastroenterology, vol. 89, No. 1, pp. 57-61 (1994). (5 pages) Cited by 10 patents [ISI abstract]
  • A. S. Muerhoff et al., Journal of Virological Methods, vol. 62, No. 1, pp. 55-62 (1996). (8 pages) Cited by 19 patents [ISI abstract]
  • P. Tijssen, "Practice and Theory of Enzyme Immunoassays" Elsevier, Amsterdam, pp. 333-340 (1985).
  • S. Vijayasarathy, Nucleic Acids Research, vol. 18, No. 10, pp. 296-2975 (1990).
  • T. Peters et al., Frequency of Hepatitis C in Acute Post-Transfusion Hepatitis After Open-Heart Surgery: A Prospective Study in 1,476 Patients, Journal of Medical Virology vol. 39:139-145 (1993). (7 pages) Cited by 9 patents [ISI abstract]
  • R. Purcell, The Discovery of the Hepatitis Viruses, Gastroenterology vol. 104 No. 4:955-963 (1993). (9 pages) Cited by 9 patents [ISI abstract]
  • G. Dawson et al., Solid-phase enzyme-linked immunosobent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides, Journal of Virological Methods vol. 38:175-186 (1992). (12 pages) Cited by 24 patents [ISI abstract]
  • P. Yarbough et al., Hepatitis E Virus: Identification of Type-Common Epitopes, Journal of Virology vol. 65 No. 11:p. 5790-5797 (1991). (8 pages) Cited by 16 patents [ISI abstract]
  • H. Alter et al., Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis, The New England Journal of Medicine vol. 321 No. 22:p 1494-1500 (1989). (7 pages) Cited by 22 patents
  • M. Alter et al., Risk Factors for Acute Non-A, Non-B Hepatitis in the United States an Association with Hepatitis C Virus Infection, JAMA vol. 264 No. 17:p. 2231-2235 (1990). (5 pages) Cited by 9 patents
  • J. Dienstag, Hepatitis Non-A, Non-B:C at last, Gastrointerology vol. 99 No. 4:pp. 1177-1180 (1990). (4 pages) Cited by 9 patents
  • G. Reyes et al., Isolation of a cDNA from the Virus Responsible for Enterically Transmitted Non-A, Non-B Hepatitis, Science vol. 247:pp.1335-1339 (1990) (5 pages) Cited by 20 patents
  • G. Kuo et al., An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis, Science vol. 244:pp. 362-364 (1989). (3 pages) Cited by 95 patents
  • A. Weiner et al., Detection of hepatitis C viral sequences in non-A, non-B hepatitis, The Lancet vol. 335:pp. 1-3 (1990). (3 pages) Cited by 46 patents
  • G. Schlauder et al., Viraemia in Egyptian children with hepatitis E virus infection, The Lancet vol. 341:pp. 378 (1993). (1 pages) Cited by 10 patents [ISI abstract]
  • N. Lisitsyn et al., Cloning the Differences Between Two Complex Genomes, Science vol. 259:pp. 946-951 (1993). (6 pages) Cited by 102 patents [ISI abstract]
  • V. Thiers et al., Post-transfusional anti-HCV-negative non-A and non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses, Journal of Hepatology vol. 18:pp.34-39 (1993). (6 pages) Cited by 9 patents [ISI abstract]
  • Hepatitis C virus upstanding, The Lancet vol. 335:pp. 1431-1432 (1990).
  • W. Parks et al., Attempted Isolation of Hepatitis Viruses in Marmosets, The Journal of Infectious Diseases vol. 120 No. 5:539-547 (1969).
  • A. Holmes et al., Specific Neutralization of Human Hepatitis Type A in Marmoset Monkeys, Nature vol. 243:pp. 419-420 (1973). (2 pages) Cited by 10 patents
  • P. Provost et al., Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326 (38578), Proceeding of the Society for Experimental Biology and Medicine vol. 148:pp. 532-539 (1975). (8 pages) Cited by 9 patents
  • Q. Choo et al., Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome, Science vol. 244:pp. 359-361 (1989). (4 pages) Cited by 142 patents
  • J. Almeida et al., Morphology of the GB hepatitis agent, Nature vol. 261:pp. 608-609(1976). (2 pages) Cited by 10 patents
  • F. Deinhart et al., Studies on the Transmission of Human Viral Hepatitis to Marmoset Monkeys, Journal of Experimental Medicine vol. 125:pp. 673-688, Plate 81-86 (1966).
  • J. Dienstag, Non-A, Non-B Hepatitis. II. Experimental Transmission, Putative Virus Agents and Markers, and Prevention, Gastroenterology vol. 85 No. 3:pp. 743-768 (1983). (26 pages) Cited by 17 patents
  • F. Hollinger et al., Transfusion-Transmitted Viruses Study: Experimental Evidence for Two Non-A Non-B Hepatitis Agents, Journal of Infectious Diseases vol. 142 No. 3:pp. 400-407 (1980). (8 pages) Cited by 18 patents
  • D. Bradley, Transmission, Etiology, and Pathogenesis of Viral Hepatitis Non-A, Non-B in Non-Human Primates, Advances in Hepatitis Research: pp. 268-280 (1984).
  • F. Deinhardt et al., Hepatitis in marmosets, The American Journal of the Medical Sciences vol. 270:pp. 73-80 (1975). (8 pages) Cited by 9 patents
  • S. Kalter, Comparison of Infectivity of Human Non-A/Non-B Hepatitis and the GB Hepatitis Agent in Marmosets, Viral and Immunological Diseases in Nonhuman Primates;:pp. 221-224 (1983).
  • E. Tabor et al., Transmission of Human Non-A, Non-B Hepatitis to Chimpanzees Following Failure to Transmit GB Agent Hepatitis, Journal of Medical Virology:pp. 103-108 (1980). (6 pages) Cited by 10 patents
  • D. Bradley et al., Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents, The Journal of Infectious Diseases vol. 148 No. 2:pp. 254-265 (1983). (12 pages) Cited by 33 patents
  • J. Dienstag, Virus-like particles and GB agent hepatitis, Nature vol. 264:pp. 260-261 (1976). (2 pages) Cited by 10 patents
  • P. Karayiannis et al. Studies of GB Hepatitis Agent in Tamarins, Hepatology vol. 9 No. 2:pp. 186-192 (1989). (7 pages) Cited by 18 patents
  • J. Melnick, Classification of Hepatitis A Virus as Enterovirus Type 72 and of Hepatitis B Virus as Hepadnavirus Type 1, Intervirology vol. 18:pp. 105-106 (1982). (2 pages) Cited by 10 patents
  • W. Parks et al., Characterization of Marmoset Hepatitis virus, The Journal of Infectious Diseases vol. 120 No. 5:pp. 548-559 (1969).
  • S. Feinstone et al., Hepatitis A: Detection by Immune electron Microscopy of a Viruslike Antigen Associated with Acute Illness, Science Vol. 182:pp. 1026-1028 (1973). (3 pages) Cited by 21 patents
  • E. Tabor et al., Lack of Susceptibility of Marmosets to human Non-A, Non-B Hepatitis, The Journal of Infectious Diseases vol. 140 No. 5:pp. 794-797 (1979). (4 pages) Cited by 10 patents
  • E. Fagan et al., Toga Virus-Like Particles in Acute Liver Failure Attributed to Sporadic Non-A, Non-B Hepatitis and Recurrence After Liver Transplantation, Journal of Medical Virology vol. 38:pp. 71-77 (1992). (7 pages) Cited by 10 patents [ISI abstract]
  • J. Dienstag, Virus particles in marmoset hepatitis, Nature Vol. 267:pp. 729-730. (1977).
  • F.Deinhardt et al., Hepatitis in Marmosets, The Journal of Infectious Diseases vol. 121 No. 3:pp. 351-354 (1970).
  • F Deinhardt et al., The Mythology of Various Hepatitis A Virus Isolates, International Symposium on Viral Hepatitis:pp. 390-404 (1975).
  • M. Alter et al., The Natural History of Community-Acquired Hepatitis C in the United States, The New England Journal of Medicine vol. 327 No. 27:pp. 1899-1905 (1992). (7 pages) Cited by 19 patents [ISI abstract]
  • R. Gibbs, Polymerase chain reaction techniques, Analytical Biotechnology:pp. 69-75 (1991). (7 pages) Cited by 9 patents [ISI abstract]
  • S. Friedman et al., The core element of the EcoRII methylase as defined by protease digestion and deletion analysis, Nucleic Acids Research vol. 19 No. 19:pp. 5403-5408 (1991). (6 pages) Cited by 10 patents [ISI abstract]
  • A. Rosenthal et al., Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction, Nucleic Acids Research vol. 18 No. 10:pp.3095-3096 (1990). (2 pages) Cited by 18 patents
  • A. Akowitz, Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease, Archives of Virology vol. 130:pp.301-316 (1993). (16 pages) Cited by 10 patents [ISI abstract]
  • Non-A, Non-B?, The Lancet vol. 2:pp. 64-65 (1975).
  • F. Hollinger, Non-A, Non-B Hepatitis Viruses, Virology:pp.2239-2273 (1990).
  • J. Dienstag, Non-A, Non-B Hepatitis I. Recognition, Epidemiology, and Clinical Features, Gastroenterology vol. 85 No. 2:pp. 439-462 (1983). (24 pages) Cited by 21 patents
  • J. Strauss et al., Structure and Function of the Flavivirus and Pestivirus Genomes, Viral Hepatitis and Liver Disease:pp. 333-344 (1990).
  • H. Alter et al., Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors, Annals of Internal Medicine vol. 77 No. 5:pp. 691-699 (1972).
  • H. Alter et al., Clinical and Serological Analysis of Transfusion-Associated Hepatitis, The Lancet:pp. 838-841 (1975). (4 pages) Cited by 14 patents
  • S. Feinstone et al., Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B, The New England Journal of Medicine vol. 292 No. 15:pp. 767-770 (1975). (4 pages) Cited by 18 patents
  • J. Simons et al., Identification of two flavivirus-like genomes in the GB Hepatitis agent, Proc. Natl. Acad. Sci. USA vol. 92:pp. 3401-3405 (1995). (5 pages) Cited by 18 patents [ISI abstract]
  • J. Simons et al., Isolation of novel virus-like sequences associated with human hepatitis, Nature Medicine vol. 1 No. 6:pp. 564-568 (1995). (6 pages) Cited by 12 patents [ISI abstract]
  • G. Schlauder et al., Molecular and Serologic Analysis in the Transmission of the GB Hepatitis Agents, Journal of Medical Virology vol. 46:pp. 81-90 (1995). (10 pages) Cited by 13 patents [ISI abstract]
  • M. Yoshiba et al., Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology, The Lancet vol. 346:pp. 1131-1132 (1995). (2 pages) Cited by 9 patents [ISI abstract]
  • J. Linnen et al., Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent, Science vol. 271:pp. 505-508 (1996). (4 pages) Cited by 12 patents [ISI abstract]
  • A. Zuckerman, The new GB hepatitis viruses, The Lancet vol. 345:pp. 1453-1455 (1995). (2 pages) Cited by 11 patents [ISI abstract]
  • L. Altman., Three Newly Discovered Viruses May Cause Unexplained Hepatitis, The New York Times Medical Science, Apr. 11, 1995.
  • L. Altman., Newly Found Viruses May Cause Hepatitis, The New York Times Medical Science, Apr. 10, 1995.
  • T. Leary et al., Sequence and Genomic Organization of GBV-C: A novel Member of the Flaviviridae Associated with Human Non-A-E Hepetitis, Journal of Medical Virology vol. 48:pp. 80-87 (1996).
  • G. Caetano-Anolles et al., DNA Amplification Fingerprinting Using Arbitrary Oligonucleotide Primers, Applied Biochemistry and Biotechnology vol. 42:pp. 189-200 (1993). (12 pages) Cited by 12 patents [ISI abstract]
  • B. Bassam, DNA amplification fingerprinting of bacteria, Applied Microbiology and Biotechnology vol. 38:pp. 70-76 (1992). (7 pages) Cited by 11 patents [ISI abstract]
  • G. Caetano-Anolles et al., DNA Amplification Fingerprinting Using Very Short Arbitrary Oligonucleotide Primers, Biotechnology vol. 9:pp. 553-557 (1991). (5 pages) Cited by 25 patents [ISI abstract]
  • J. Welsh et al., Fingerprinting genomes using PCR with arbitrary primers*, Nucleic Acids Research vol. 18 No. 24:pp. 7213-7218 (1990). (6 pages) Cited by 54 patents
  • J. Welsh et al., Arbitrarily Primed PCR fingerprinting of RNA, Nucleic Acids Research vol. 20 No. 19:pp. 4965-4970 (1992). (6 pages) Cited by 55 patents [ISI abstract]
  • J. Williams et al., DNA polymorphisms amplified by arbitrary primers are useful as genetic markers, Nucleic Acids Research vol. 18 No. 22:pp. 6531-6535 (1990). (5 pages) Cited by 69 patents
  • P. Liang et al., Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction, Science vol. 257:pp. 967-971 (1992). (5 pages) Cited by 185 patents [ISI abstract]
  • P. Liang et al., Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization, Nucleic Acids Research vol. 21 No. 14:pp. 3269-3275 (1993). (7 pages) Cited by 55 patents [ISI abstract]


    • Inquire Regarding Licensing

    Powered by Verity
    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help